Document is current
Any future updates will be listed below
-
Authors
Kumar, Vivek
Ailawadhi, Sikander
Bojanini, Leyla
Mehta, Aditya
Biswas, Suman
Sher, Taimur
Roy, Vivek
Vishnu, Prakash
Marin-Acevedo, Julian https://orcid.org/0000-0001-7067-173X
Alegria, Victoria R.
Paulus, Aneel
Aulakh, Sonikpreet
Iqbal, Madiha https://orcid.org/0000-0001-6752-5440
Manochakian, Rami
Tan, Winston
Chanan-Khan, Asher
Ailawadhi, Meghna
- License Information
-
More Information
Article History
Received: 27 January 2019
Revised: 23 May 2019
Accepted: 25 July 2019
First Online: 30 September 2019
Conflict of interest
: S. Ai serves as a consultant for Celgene, Takeda, Janssen, Pharmacyclics, and Amgen, and has received institutional research support from Pharmacyclics, Cellectar, and Amgen; R.M. has served as an advisor for Takeda, Guardant Health, AstraZanaca, and Novocure; M.A. has an immediate family member as a consultant for Celgene, Takeda, Janssen, Pharmacyclics, and Amgen, and who has received institutional research support from Pharmacyclics, Cellectar, and Amgen. The other authors declare that they have no conflict of interest.
